Last updated on December 2017

The DAYBREAK Study


Brief description of study

The DAYBREAK Study

Detailed Study Description

This study is testing an oral investigational study drug in people who have been experiencing a decline in memory function, and/or who have been diagnosed with mild Alzheimer’s disease. The main objective of the study is to see whether this drug can slow the decline in memory and mental functioning that occurs in Alzheimer’s disease.

Clinical Study Identifier: TX147533

Contact Investigators or Research Sites near you

Start Over

Margie Pazzi, RN, BSN

Center for Neurosciences
Tucson, AZ USA
  Connect »